How did SEM's revenue and expenses trend in Q4 2024?

Select Medical (SEM) exhibited a consistent cost of goods sold (COGS) of $36.91 million across all segments for Q4 2024, reflecting stable operating costs. The revenue by business segment showed a diversified pattern with varying segment revenues, highlighting the company's broad service offerings. Here's a detailed analysis of SEM's revenue and expense trends in Q4 2024:

1. **Revenue Trend**: SEM's revenue by business segment included:
- Critical Illness Recovery Hospital: $2.44 billion
- Concentra: $1.84 billion
- Outpatient Rehabilitation: $1.44 billion
- Rehabilitation Hospital: $1.25 billion
- Other: $382.02 million
- Other: $283.85 million
2. **Segment Breakdown**: The segments contributed to the overall revenue, with Critical Illness Recovery Hospital and Concentra being the highest revenue generators.
3. **Cost Stability**: The COGS of $36.91 million remained unchanged across all segments, indicating efficient cost management by SEM.
4. **Operating Expenses**: The operating expenses for Q4 2024 were not provided, but it's important to note that these expenses are essential in understanding the company's overall profitability.

In conclusion, SEM demonstrated a stable revenue trend with strong contributions from its business segments, while maintaining a consistent cost of operations. The absence of operating expenses data prevents a complete analysis of profitability, but the company's revenue segmentation provides a clear picture of its service performance.